Penumbra, Inc. (PEN) SEC Filings & Earnings Calls

Acquisition completion risk: pending acquisition by Boston Scientific may not close as expected.

“Risk that the pending acquisition by Boston Scientific Corporation will not be completed in the expected timeframe or at all.” · word for word

Employee retention and management distraction during acquisition process.

“Potential adverse effects to our business during the pendency of the acquisition, such as employee departures or diversion of management’s attention.” · word for word

Merger Completion Risk

“The consummation of the Merger is expected to be completed in 2026, subject to regulatory approvals and other customary closing conditions.” · word for word

Tax Rate Increase

“Income tax expense was $11.4 million or 24.6% of income before taxes ... compared to an immaterial amount or 0.1% of income before taxes ... The change in effective tax rate was primarily due to a decrease in excess tax benefits from stock-based compensation” · word for word

Merger completion risk

“The consummation of the Merger is expected to be completed in 2026, subject to approval by the Company’s shareholders, regulatory approvals, and other customary closing conditions.” · word for word

Termination fee exposure

“Upon termination of the Merger Agreement in accordance with its terms, under specified circumstances, the Company will be required to pay Parent a termination fee in an amount equal to $525.0 million.” · word for word

Operating margin pressure

“Income from operations $38,234 $40,350”

Pending acquisition by Boston Scientific may not close in expected timeframe or at all

“the risk that the pending acquisition by Boston Scientific Corporation will not be completed in the expected timeframe or at all, including the risk that required regulatory approvals will not be obtained” · word for word

Potential adverse effects during pendency of acquisition, including employee departures and management distraction

“potential adverse effects to our business during the pendency of the acquisition, such as employee departures or diversion of management’s attention from our business” · word for word

Merger Completion Risk

“The failure to complete the Merger could adversely affect our business.” · word for word

Customer/Employee Distraction

“Uncertainty about the effect of the Merger Agreement and the Merger on our customers, employees, suppliers, vendors, and business partners may have an adverse effect on our business and operations” · word for word

Pending acquisition introduces deal execution and integration risk.

“Given the proposed acquisition of Penumbra, Inc. by Boston Scientific Corporation... the Company will not be providing financial guidance for the full year 2026.” · word for word

Transaction subject to stockholder approval and customary closing conditions; expected dilutive to Boston Scientific EPS in first year

“transaction is expected to be $0.06-0.08 dilutive to adjusted earnings per share for Boston Scientific in the first full year” · word for word

Litigation risk

“Settled wage and hour class action for $4.6M.”

Execution risk on capex

“Costa Rica facility expected to cost ~$58M; payments of $28.3M made so far.”